Noyori, Ryöji
Publication with MATCHING institution:
- Noyori R, Suga S, Oka H, Kitamura M (2001) Self and nonself recognition of chiral catalysts: the origin of nonlinear
effects in the amino-alcohol catalyzed asymmetric addition of diorganozincs to aldehydes. Chemical Record. [IF=1.183,
Cited=14, 11893067].
- Hayakawa Y, Kawai R, Hirata A, ..., Noyori R (2001) Acid/azole complexes as highly effective promoters in the synthesis
of DNA and RNA oligomers via the phosphoramidite method. Journal of the American Chemical Society. [IF=2.573, Cited=23, 11516266].
- Kitamura M, Nakano K, Miki T, ..., Noyori R (2001) Stereochemistry of aldols: configuration and conformation of aldols
derived from cycloalkanones and aldehydes. Journal of the American Chemical Society. [IF=2.573, Cited=11, 11552800].
- Suzuki M, Kiho T, Tomokiyo K, ..., Noyori R (1998) Rational design of antitumor prostaglandins with high biological
stability. Journal of Medicinal Chemistry. [IF=1.655, Cited=22, 9685248].
- Abarbri M, Parrain J, Kitamura M, ..., Duchene A (2000) Palladium-catalyzed cross-coupling of 3-iodobut-3-enoic acid
with organometallic reagents. Synthesis Of 3-substituted but-3-enoic acids. Journal of Organic Chemistry. [IF=0.885,
Cited=2, 11076605].
- Noyori R, Yamakawa M, Hashiguchi S (2001) Metal-ligand bifunctional catalysis: a nonclassical mechanism for asymmetric
hydrogen transfer between alcohols and carbonyl compounds. Journal of Organic Chemistry. [IF=0.885, Cited=173, 11722188].
- Ohkuma T, Koizumi M, Yoshida M, Noyori R (2000) General asymmetric hydrogenation of hetero-aromatic ketones. Organic
Letters. [IF=1.091, Cited=30, 10880217].
- Yamada I, Noyori R (2000) Asymmetric transfer hydrogenation of benzaldehydes. Organic Letters. [IF=1.091, Cited=19, 11081999].
- Ohkuma T, Koizumi M, Ikehira H, ..., Noyori R (2000) Selective hydrogenation of benzophenones to benzhydrols. Asymmetric
synthesis of unsymmetrical diarylmethanols. Organic Letters. [IF=1.091, Cited=37, 10814403].
- Tominaga A, Saito S, Kohno S, ..., Noyori R (1990) Antiviral effects of 2',5'oligoadenylates (2-5As), and related
compounds. Microbiology and Immunology. [IF=0.571, Cited=2, 2178211].
- Noyori R (1990) Chiral metal complexes as discriminating molecular catalysts. Science. [IF=7.729, Cited=36, 17809904].
- Noyori R (1992) Organic synthesis: current status in Japan. Science. [IF=7.729, Cited=0, 17748891].
- Sato K, Aoki M, Noyori R (1998) A "Green" route to adipic acid: direct oxidation of cyclohexenes with 30 percent
hydrogen peroxide. Science. [IF=7.729, Cited=89, 9733504].
- Noyori R, Suzuki M (1993) Organic synthesis of prostaglandins: advancing biology. Science. [IF=7.729, Cited=37, 8418493].
- Noyori R, Yanagisawa A, Koyano H, Suzuki M (1989) Natural and unnatural prostaglandins via the three-component coupling
synthesis. None. [IF=None, Cited=0, 2526549].
Publication with MISMATCHING institution:
- Jessop PG, Ikariya T, Noyori R (1995) Homogeneous catalysis in supercritical fluids. Science. [IF=7.729, Cited=22, 17755526].
Publication with MISSING institution:
- Mikami K, Korenaga T, Ohkuma T, Noyori R (2000) Asymmetric Activation/Deactivation of Racemic Ru Catalysts for Highly
Enantioselective Hydrogenation of Ketonic Substrates We are grateful to Drs. H. Kumobayashi and N. Sayo of the Takasago
International Corp. for providing the BINAP ligands. We also thank Dr. Kenji Yoza of the Nippon Bruker Co. for X-ray
analysis of the. Angewandte Chemie - International Edition. [IF=2.456, Cited=10, 11091449].
- Akimaru K, Nakanishi M, Suzuki M, ..., Ishikawa T (1997) Cell growth inhibition by antitumor prostaglandin and its
modulation by MRP/GS-X pump. Advances in Experimental Medicine and Biology. [IF=0.945, Cited=5, 9321981].
- Akimaru K, Kuo MT, Furuta K, ..., Ishikawa T (1996) Induction of MRP/GS-X pump and cellular resistance to anticancer
prostaglandins. Cytotechnology. [IF=0.589, Cited=8, 8862010].
- Corey EJ, Corey EJ, Corey EJ, ..., Noyori R (1970) A total synthesis of prostaglandin F2-alpha (dl) from
2-oxabicyclo[3.3.0]oct-6-en-3-one. Tetrahedron Letters. [IF=0.515, Cited=8, 5414678].
- Kitamura M, Suga S, Kawai K, Noyori R (1986) Catalytic asymmetric induction. Highly enantioselective addition of
dialkylzincs to aldehydes. Journal of the American Chemical Society. [IF=2.573, Cited=57, 22175391].
- Noyori R, Kumagai Y, Umeda I, Takaya H (1972) Localization of tyrosine at the binding site of neurophysin II by negative
nuclear Overhauser effects. Journal of the American Chemical Society. [IF=2.573, Cited=33, 5037990].
- Sobue M, Habuchi H, Ito K, ..., Suzuki S (1987) beta-D-xylosides and their analogues as artificial initiators of
glycosaminoglycan chain synthesis. Aglycone-related variation in their effectiveness in vitro and in ovo. Biochemical
Journal. [IF=0.852, Cited=55, 3109379].
- Ishikawa T, Akimaru K, Nakanishi M, ..., Noyori R (1998) Anti-cancer-prostaglandin-induced cell-cycle arrest and its
modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump). Biochemical Journal.
[IF=0.852, Cited=19, 9841867].
- Satoh T, Ishikawa Y, Kataoka Y, ..., Watanabe Y (1999) CNS-specific prostacyclin ligands as neuronal survival-promoting
factors in the brain. European Journal of Neuroscience. [IF=0.891, Cited=24, 10510175].
- Matsumura K, Takechi H, Kato K, ..., Watanabe Y (1999) A novel subtype of prostacyclin receptor in the central nervous
system. Journal of Neurochemistry. [IF=1.089, Cited=19, 10349870].
- Takechi H, Matsumura K, Kato K, ..., Watanabe Y (1996) A novel subtype of the prostacyclin receptor expressed in the
central nervous system. Journal of Biological Chemistry. [IF=1.122, Cited=41, 8621463].
- Tanikawa M, Yamada K, Tominaga K, ..., Nakanishi M (1998) Potent prostaglandin A1 analogs that suppress tumor cell
growth through induction of p21 and reduction of cyclin E. Journal of Biological Chemistry. [IF=1.122, Cited=26, 9660822].
- Fukushima S, Takeuchi Y, Kishimoto S, ..., Fukushima M (2001) Antitumor activity, optimum administration method and
pharmacokinetics of 13,14-dihydro-15-deoxy-deoxy-Delta7 -prostaglandin A1 methyl ester (TEI-9826) integrated in lipid
microspheres (Lipo TEI-9826). Anti-Cancer Drugs. [IF=0.469, Cited=6, 11290870].
- Sugiura S, Toru T, Tanaka T, ..., Noyori R (1984) Synthesis of new antineoplastic prostaglandins. Chemical and
Pharmaceutical Bulletin. [IF=0.569, Cited=9, 6532563].
- Sugiura S, Hazato A, Tanaka T, ..., Noyori R (1985) Synthesis of new antineoplastic alkylidenecyclopentenones. Chemical
and Pharmaceutical Bulletin. [IF=0.569, Cited=5, 4092307].
- Björkman M, Andersson Y, Doi H, ..., Långström B (1998) Synthesis of 11C/13C-labelled prostacyclins. None. [IF=None,
Cited=11, 9586195].
- Hayakawa Y, Hayakawa M, Hirose M, Noyori R (1992) Partial methyl phosphotriester-modification of
oligodeoxyribonucleotides. None. [IF=None, Cited=0, 1289778].
- Ito S, Hashimoto H, Negishi M, ..., Ichikawa A (1992) Identification of the prostacyclin receptor by use of
[15-3H1]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity probe. Journal of Biological
Chemistry. [IF=1.122, Cited=8, 1400351].
- Hayakawa Y, Harada H, Hirose M, ..., Kato I (1991) Direct synthesis of solid-anchored DNA oligomers. None. [IF=None,
Cited=0, 1842098].
- Hayakawa Y, Hirose M, Noyori R (1990) Allyl protection of O6 position of 2'-deoxyguanosine. None. [IF=None, Cited=1, 2101882].
- Hayakawa Y, Hirose M, Noyori R (1989) General, regiocontrolled synthesis of unsymmetrically linked dinucleoside
adenosine 2',3'-bis(phosphate)s. None. [IF=None, Cited=0, 2608452].
- Noyori R, Suzuki M (1985) Convergent synthesis of prostaglandins. None. [IF=None, Cited=0, 2936109].
- Kurozumi S, Tanaka T, Okamura N, ..., Noyori R (1985) Three-component coupling process to synthesize prostaglandin
analogues of pharmacological interest. None. [IF=None, Cited=0, 2936110].
- Mitsuhira Y, Tahara S, Goto K, ..., Noyori R (1988) Application of allyloxycarbonyl group as a protecting group to
oligodeoxyribonucleotide synthesis. None. [IF=None, Cited=0, 3226919].
- Hayakawa Y, Kato H, Nobori T, ..., Imai J (1986) Allyl and allyloxycarbonyl groups as versatile protecting groups in
nucleotide synthesis. None. [IF=None, Cited=0, 3562287].
- Kato T, Fukushima M, Kurozumi S, Noyori R (1986) Antitumor activity of delta 7-prostaglandin A1 and delta
12-prostaglandin J2 in vitro and in vivo. Cancer Research. [IF=1.624, Cited=43, 3708585].
- Hayakawa Y, Nobori T, Noyori R (1985) Synthesis of 2'-end-modified 2'-5'-oligoadenylates. None. [IF=None, Cited=0, 4088856].
- Hayakawa Y, Uchiyama M, Noyori R (1985) A convenient method for the oxidation of nucleoside phosphites to phosphates.
None. [IF=None, Cited=0, 4088859].
- Sato T, Noyori R (1979) The stereocontrolled synthesis of homo-C-nucleosides. None. [IF=None, Cited=0, 547235].
- Hayakawa Y, Uchiyama M, Nobori T, Noyori R (1984) A convenient synthesis of adenylyl-(2'----5')-adenylyl-(2'----
5')-adenosine (2-5A core). None. [IF=None, Cited=0, 6522298].
- Hayakawa Y, Aso Y, Uchiyama M, Noyori R (1983) Chemoselective phosphorylation of N-unblocked nucleosides. None.
[IF=None, Cited=0, 6664872].
- Hayakawa Y, Aso Y, Uchiyama M, Noyori R (1982) A new phosphorylation method for the nucleotide synthesis. None.
[IF=None, Cited=0, 7183973].
- Hirose M, Noyori R, Hayakawa Y (1993) Synthesis of phenylphosphonodiester-modified oligodeoxyribonucleotides via the
allyl protection. None. [IF=None, Cited=0, 8247798].
- Fukushima S, Kishimoto S, Takeuchi Y, ..., Kurozumi S (1998) [Pharmaceutical and pharmacological development of
antitumor prostaglandins]. None. [IF=None, Cited=1, 9549353].